Translate the text from Welsh to English.



 
Rwyf am roi'r wybodaeth ddiweddaraf i'r aelodau am gyngor diweddaraf y Cyd\-bwyllgor ar Imiwneiddio a Brechu (JCVI), a gyhoeddwyd heddiw, ar frechu plant a phobl ifanc rhag COVID\-19\.


Cyngor y Cyd\-bwyllgor yw cynnig dos cychwynnol o frechlyn Pfizer i bob person ifanc 16 ac 17 oed nad ydynt wedi cael eu brechu. Mae hyn yn ychwanegol at y cynnig presennol o ddau ddos o frechlyn i bobl ifanc 16\-17 oed sydd mewn grwpiau ‘risg’. 


Rydym eisoes yn gwahodd pobl ifanc sydd o fewn tri mis i'w pen\-blwydd yn 18 oed i gael eu brechu, yn unol â chyngor y Cyd\-bwyllgor.  


Nid yw'r cyngor ynglŷn â phobl ifanc 12\-15 oed wedi newid, sef y dylid cynnig dau ddos o frechlyn Pfizer i’r rhai rhwng 12 a 15 oed sydd â chyflyrau iechyd sylfaenol penodol sy’n golygu bod risg iddynt gael COVID\-19 difrifol, fel y nodir yn y Llyfr Gwyrdd, gyda chyfnod o wyth wythnos rhwng dosau.


Hefyd, mae plant a phobl ifanc 12 oed a throsodd sydd wedi dod i gysylltiad gartref ag unigolion (oedolion neu blant) sydd heb imiwnedd, bellach yn cael cynnig y brechlyn. Mae gan bobl sy’n imiwnoataliedig system imiwnedd wannach. Maent yn fwy tebygol o gael canlyniadau gwaeth os ydynt yn cael eu heintio â COVID\-19\. Bydd brechu cysylltiadau cartref yn helpu i gyfyngu ar ledaeniad y feirws.


Mae'r Cyd\-bwyllgor yn nodi bod data a phrofiad pellach yn cronni o ran brechu pobl 12\-15 oed sydd fel arall yn iach. Mae epidemioleg bresennol COVID\-19 yn y DU hefyd yn newid yn gyflym. Mae’r Cyd\-bwyllgor o'r farn bod y ffactorau hyn yn bwysig wrth bennu'r cydbwysedd cyffredinol rhwng y niwed a’r budd sy'n gysylltiedig â brechu pobl ifanc 12\-15 oed iach, a bydd yn parhau i adolygu data sy'n dod i'r amlwg ac yn rhoi cyngor pellach mewn modd amserol.


Ym mhob achos, rhaid i'r cynnig i frechu plant a phobl ifanc gynnwys gwybodaeth briodol i alluogi plant a phobl ifanc, a'r rhai sydd â chyfrifoldeb rhiant drostynt, i wybod digon am niwed a manteision posibl brechu fel rhan o gydsyniad gwybodus cyn brechu.


Yn unol â chenhedloedd eraill y DU, mae Llywodraeth Cymru yn croesawu cyngor diweddaraf y Cyd\-bwyllgor ar Imiwneiddio a Brechu ac yn diolch iddynt am eu harbenigedd a’u barn ystyriol ar faterion mor bwysig.  Rydym bellach yn gweithio gyda'r GIG ar y trefniadau sydd eu hangen i gynnig y brechlyn i bob plentyn 16 ac 17 oed yn unol â chyngor y Cyd\-bwyllgor.


Mae'r datganiad hwn yn cael ei wneud yn ystod y toriad er mwyn rhoi'r wybodaeth ddiweddaraf i'r aelodau. Pe bai aelodau'n dymuno imi wneud datganiad pellach neu ateb cwestiynau ar hyn pan fydd y Senedd yn dychwelyd, byddwn yn hapus i wneud hynny.







Translation:


 
I want to provide members with an update on the Joint Committee for Vaccination and Immunisation (JCVI) latest advice, published today, for COVID\-19 Vaccination of children and young people.


The JCVI advise to offer an initial dose of Pfizer vaccine to all 16 and 17 year olds who haven’t been vaccinated.  This is in addition to the existing offer of two doses of vaccine to 16\-17 year olds who are in ‘at\-risk’ groups.


We are already inviting young people who are within three months of their 18th birthday, in line with JCVI advice.


The advice on 12\-15 year olds has not changed and remains that persons aged 12\-15 years with specific underlying health conditions that put them at risk of severe COVID\-19, as set out in the Green Book, should be offered two doses of Pfizer vaccine with an interval of eight weeks between doses.


Also, children and young people aged 12 years and over who are household contacts of persons (adults or children) who are immunosuppressed are now being offered the vaccine.a. People who are immunosuppressed have a weaker immune system. They are more likely to have poorer outcomes if they get infected with COVID\-19\. Vaccinating household contacts will help limit the spread of the virus.


The JCVI note that further data and experience relevant to the vaccination of otherwise healthy persons aged 12\-15 years are accumulating. The current epidemiology of COVID\-19 in the UK is also changing rapidly. JCVI considers these factors important in determining the overall harm\-benefit balance related to the vaccination of healthy 12\-15 year olds and will continue to review emerging data and provide further advice in a timely manner.


In all instances, the offer of vaccination to children and young people must be accompanied by appropriate information to enable children and young people, and those with parental responsibility, to be adequately appraised of the potential harms and benefits of vaccination as part of informed consent prior to vaccination.


In line with the other nations of the UK, the Welsh Government welcomes the latest JCVI advice and thank them for their expertise and considered judgement on such important issues.  We are now working with the NHS on the arrangements needed to offer the vaccination to all 16 and 17 year olds in line with the JCVI advice.


This statement is being issued during recess in order to keep members informed. Should members wish me to make a further statement or to answer questions on this when the Senedd returns I would be happy to do so.